Zynerba Pharmaceuticals IPO Info
Company Name: Zynerba Pharmaceuticals
Stock Symbol: ZYNE
Exchange: NASDAQ
Status: Priced
IPO Date: 8/5/2015
IPO Price:
14.00 (
-28.07%)
Underwriters
Jefferies, Piper Jaffray, Canaccord Genuity, Oppenheimer & Co.
Amount of Offering: N/A
Number of Shares Offered: 3 Mil
Shares Outstanding After Offering: N/A
Valuation: N/A
Company Description
Zynerba Pharma is a ten-year-old specialty pharmaceutical company focused on developing and commercializing proprietary next-generation synthetic cannabinoid therapeutics formulated for transdermal delivery. The company said, "Our management team is highly experienced and has a successful history of development, regulatory approval and commercialization of patch and gel transdermal delivery products. We are evaluating two patent-protected product candidates, ZYN002 and ZYN001, in five indications. We intend to study ZYN002 in patients with refractory epilepsy, Fragile X syndrome, or FXS, and osteoarthritis, or OA. We intend to study ZYN001 in patients with fibromyalgia and peripheral neuropathic pain. We expect to initiate Phase 1 clinical trials for ZYN002 in the second half of 2015 and ZYN001 by mid-2016."
SEC Filings
News Headlines
